Liven Pharma Limited (PSX:LIVEN)

Liven Pharma Revenue

In the fiscal year ending June 30, 2025, Liven Pharma had annual revenue of 127.27M PKR, down -48.07%. Liven Pharma had revenue of 6.48M in the quarter ending June 30, 2025, a decrease of -97.36%.

• Revenue: 127.27M
• Revenue Growth: -48.07%
• P/S Ratio: 41.66
• Revenue / Employee: 3.10M
• Employees: 41
• Market Cap: 5.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	127.27M	-117.82M	-48.07%
Jun 30, 2024	245.09M	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	-	-	-
Jun 30, 2021	-	-	-